Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
Open accessAbstract
How the brain’s antioxidant defenses adapt to changing demand is incompletely understood. Here we show that synaptic activity is coupled, via the NMDA receptor (NMDAR), to control of the glutathione antioxidant system. This tunes antioxidant capacity to reflect the elevated needs of an active neuron, guards against future increased demand and maintains redox balance in the brain. This control is mediated via a programme of gene expression changes that boosts the synthesis, recycling and utilization of glutathione, facilitating ROS detoxification and preventing Puma -dependent neuronal apoptosis. Of particular importance to the developing brain is the direct NMDAR-dependent transcriptional control of glutathione biosynthesis, disruption of which can lead to degeneration. Notably, these activity-dependent cell-autonomous mechanisms were found to cooperate with non-cell-autonomous Nrf2-driven support from astrocytes to maintain neuronal GSH levels in the face of oxidative insults. Thus, developmental NMDAR hypofunction and glutathione system deficits, separately implicated in several neurodevelopmental disorders, are mechanistically linked.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NMDAR antagonism likely induces a hyperglutamatergic state by reducing the activity of cortical interneurons, which particularly rely on NMDARs for their excitatory drive early in development.
“NMDAR antagonism likely induces a hyperglutamatergic state by reducing the activity of cortical interneurons, which particularly rely on NMDARs for their excitatory drive early in development 29,79 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
[12] Assays of glutathione peroxidase
Flohé, L., & Günzler, W. A. (1984) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(84)05015-1 · Cited by 4,954 · see citing works
Griffith, O. W. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90139-6 · Cited by 4,628 · see citing works
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,659 · see citing works
Synaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747 · see citing works
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · see citing works
Self-citationp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327 · see citing works
Biologic and pharmacologic regulation of mammalian glutathione synthesis
Griffith, O. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00176-8 · Cited by 1,195 · see citing works
An optimized fluorescent probe for visualizing glutamate neurotransmission
Marvin, J. S., Borghuis, B. G., Tian, L., Cichon, J., Harnett, M. T., Akerboom, J., Gordus, A. G., Renninger, S. L., Chen, T., Bargmann, C. I., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2333 · Cited by 1,006 · see citing works
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909 · see citing works
Real-time imaging of the intracellular glutathione redox potential
Gutscher, M., Pauleau, A.-L., Marty, L., Brach, T., Wabnitz, G. H., Samstag, Y., Meyer, A. J., & Dick, T. P. (2008) · Nature Methods · doi:10.1038/nmeth.1212 · Cited by 894 · see citing works
Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., & Murphy, T. H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03394.2003 · Cited by 786 · see citing works
Glutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597 · see citing works
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 555 · see citing works
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M. J., Chowdhry, S., & Dinkova‐Kostova, A. T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 540 · see citing works
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation
Brennan, A. M., Suh, S. W., Won, S. J., Narasimhan, P., Kauppinen, T. M., Lee, H., Edling, Y., Chan, P. H., & Swanson, R. A. (2009) · Nature Neuroscience · doi:10.1038/nn.2334 · Cited by 538 · see citing works
Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity
Hardingham, G. E., Arnold, F. J. L., & Bading, H. (2001) · Nature Neuroscience · doi:10.1038/85109 · Cited by 537 · see citing works
Self-citationSynaptic NMDA receptor activity boosts intrinsic antioxidant defenses
Papadia, S., Soriano, F. X., Léveillé, F., Martel, M.-A., Dakin, K. A., Hansen, H. H., Kaindl, A., Sifringer, M., Fowler, J., Stefovska, V., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2071 · Cited by 498 · see citing works
Self-citationKantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 397 · see citing works
Redox dysregulation, neurodevelopment, and schizophrenia
Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works
Xia, P., Chen, H.-S. V., Zhang, D., & Lipton, S. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2488-10.2010 · Cited by 380 · see citing works
Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation
Lipton, S. A., Choi, Y.-B., Takahashi, H., Zhang, D., Li, W., Godzik, A., & Bankston, L. A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02245-2 · Cited by 375 · see citing works
Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses
Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Bernardina, B. D., & Bonassi, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.011 · Cited by 370 · see citing works
Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
Johnson, W. M., Wilson‐Delfosse, A. L., & Mieyal, J. J. (2012) · Nutrients · doi:10.3390/nu4101399 · Cited by 354 · see citing works
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309 · see citing works
Fluorescence-based microtiter plate assay for glutamate–cysteine ligase activity
White, C. C., Viernes, H., Krejsa, C. M., Botta, D., & Kavanagh, T. J. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00143-x · Cited by 293 · see citing works
Yates, M. S., Tauchi, M., Katsuoka, F., Flanders, K. C., Liby, K. T., Honda, T., Gribble, G. W., Johnson, D. A., Johnson, J. A., Burton, N. C., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0516 · Cited by 292 · see citing works
The Nrf2–ARE cytoprotective pathway in astrocytes
Vargas, M. R., & Johnson, J. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001094 · Cited by 289 · see citing works
Qiu, J., Tan, Y.-W., Hagenston, A. M., Martel, M., Kneisel, N., Skehel, P., Wyllie, D. J. A., Bading, H., & Hardingham, G. E. (2013) · Nature Communications · doi:10.1038/ncomms3034 · Cited by 267 · see citing works
Self-citationMonochlorobimane Fluorometric Method to Measure Tissue Glutathione
Kamencic, H., Lyon, A. W., Paterson, P. G., & Juurlink, B. H. J. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4765 · Cited by 265 · see citing works
Papadia, S., Stevenson, P., Hardingham, N. R., Bading, H., & Hardingham, G. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5019-04.2005 · Cited by 262 · see citing works
Self-citationAntioxidant and bioenergetic coupling between neurons and astrocytes
Fernandez-Fernandez, S., Almeida, A., & Bolaños, J. P. (2012) · Biochemical Journal · doi:10.1042/bj20111943 · Cited by 247 · see citing works
Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration
Fredriksson, A., Archer, T., Alm, H., Gordh, T., & Eriksson, P. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.12.026 · Cited by 238 · see citing works
Cabungcal, J.-H., Steullet, P., Kraftsik, R., Cuenod, M., & Do, K. Q. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.020 · Cited by 232 · see citing works
Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase.
Tate, S. S., & Meister, A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4806 · Cited by 219 · see citing works
Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia
Cabungcal, J.-H., Counotte, D. S., Lewis, E. M., Tejeda, H. A., Piantadosi, P., Pollock, C., Calhoon, G. G., Sullivan, E. M., Presgraves, E., Kil, J., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.028 · Cited by 204 · see citing works
Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202 · see citing works
Glutathione and Signal Transduction in the Mammalian CNS
Janáky, R., Ogita, K., Pasqualotto, B. A., Bains, J. S., Oja, S. S., Yoneda, Y., & Shaw, C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730889.x · Cited by 194 · see citing works
Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173 · see citing works
Long‐term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism
Harris, L. W., Sharp, T., Gartlon, J. E., Jones, D. N. C., & Harrison, P. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02902.x · Cited by 162 · see citing works
γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor
Quintana–Cabrera, R., Fernández-Fernández, S., Bobo-Jiménez, V., Escobar, J., Sastre, J., Almeida, Á., & Bolaños, J. P. (2012) · Nature Communications · doi:10.1038/ncomms1722 · Cited by 162 · see citing works
Stephenson, D. T., Rash, K. S., Smalstig, B., Roberts, E. F., Johnstone, E., Sharp, J., Panetta, J., Little, S. P., Kramer, R. M., & Clemens, J. A. (1999) · Glia · doi:10.1002/(sici)1098-1136(199908)27:2 · Cited by 152 · see citing works
M, T., Abazyan, S., Abazyan, B. N., Nomura, J., Yang, C., Seshadri, S., Sawa, A., Snyder, S. H., & Pletnikov, M. V. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.97 · Cited by 151 · see citing works
Soriano, F. X., Léveillé, F., Papadia, S., Higgins, L. G., Varley, J. A., Baxter, P. S., Hayes, J. D., & Hardingham, G. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05648.x · Cited by 144 · see citing works
Self-citationPuma Is a Dominant Regulator of Oxidative Stress Induced Bax Activation and Neuronal Apoptosis
Steckley, D., Karajgikar, M., Dale, L. B., Fuerth, B. J., Swan, P., Drummond-Main, C., Poulter, M. O., Ferguson, S. S. G., Strasser, A., & Cregan, S. P. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3400-07.2007 · Cited by 142 · see citing works
Self-citationHongpaisan, J., Winters, C. A., & Andrews, S. B. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3278-04.2004 · Cited by 138 · see citing works
DISC1 at 10: connecting psychiatric genetics and neuroscience
Porteous, D. J., Millar, J. K., Brandon, N. J., & Sawa, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.09.002 · Cited by 137 · see citing works
Glutathione-Related Factors and Oxidative Stress in Autism, A Review
Ghanizadeh, A. J., Akhondzadeh, S., Hormozi, M., Makarem, A., Zarchi, M. A., & Firoozabadi, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712802002572 · Cited by 134 · see citing works
Spain, A., Daumas, S., Lifshitz, J., Rhodes, J. K. J., Andrews, P., Horsburgh, K. J., & Fowler, J. H. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1288 · Cited by 133 · see citing works
Bell, K. F., Al-Mubarak, B., Fowler, J. H., Baxter, P. S., Gupta, K., Tsujita, T., Chowdhry, S., Patani, R., Chandran, S., Horsburgh, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015229108 · Cited by 133 · see citing works
Self-citationOrwar, O., Fishman, H. A., Ziv, N. E., Scheller, R. H., & Zare, R. N. (1995) · Analytical Chemistry · doi:10.1021/ac00119a010 · Cited by 130 · see citing works
Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., & Do, K. Q. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4858 · Cited by 124 · cited 6× · see citing works
“The genetic associations with GCLC are particularly intriguing in the light of studies that show disease-relevant phenotypes in mouse models of GSH deficiency, triggered by both genetic and pharmacological means 5 .”
InfluentialMonin, A., Baumann, P. S., Griffa, A., Xin, L., Mekle, R., Fournier, M., Butticaz, C., Klaey, M., Cabungcal, J. H., Steullet, P., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.88 · Cited by 113 · see citing works
Drake, J., Kański, J., Varadarajan, S., Tsoras, M., & Butterfield, D. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10266 · Cited by 110 · see citing works
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells*
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 108 · see citing works
(2011) · Proceedings of the National Academy of Sciences · doi:10.1073/iti0111108 · Cited by 104 · see citing works
Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders
Carlson, G. C. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.003 · Cited by 102 · see citing works
The enigma of fetal alcohol neurotoxicity
Olney, J. W., Wozniak, D. F., Farber, N. B., Jevtović‐Todorović, V., Bittigau, P., & Ikonomidou, C. (2002) · Annals of Medicine · doi:10.1080/07853890252953509 · Cited by 101 · see citing works
Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
da Silva, F. C. C., Citó, M. D. C. D. O., Silva, M. I. G., Moura, B. A., Neto, M. R. D. A., Feitosa, M. L., Chaves, R. D. C., Macêdo, D. S., Vasconcelos, S. M. M., Fonteles, M. M. D. F., et al. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.05.011 · Cited by 99 · see citing works
Sun, X., Shih, A. Y., Johannssen, H. C., Erb, H., Li, P., & Murphy, T. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601567200 · Cited by 89 · see citing works
Gupta, K., Patani, R., Baxter, P. S., Serio, A., Story, D., Tsujita, T., Hayes, J. D., Pedersen, R. A., Hardingham, G. E., & Chandran, S. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.154 · Cited by 86 · see citing works
Self-citationDiaz-Hernandez, J. I., Almeida, A., Delgado-Esteban, M., Fernandez, E., & Bolaños, J. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507065200 · Cited by 82 · see citing works
Triggers of apoptosis in the immature brain
Ikonomidou, C. (2009) · Brain and Development · doi:10.1016/j.braindev.2009.02.006 · Cited by 80 · see citing works
The influence of synaptic activity on neuronal health
Bell, K. F., & Hardingham, G. E. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.01.002 · Cited by 77 · see citing works
Self-citationRadonjić, N. V., Knežević, I. D., Vilimanovich, U., Kravić-Stevović, T., Marina, L. V., Nikolić, T., Todorović, V., Bumbaširević, V., & Petronijević, N. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.009 · Cited by 75 · see citing works
CNS Peroxiredoxins and Their Regulation in Health and Disease
Bell, K. F. S., & Hardingham, G. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3567 · Cited by 71 · see citing works
Self-citationHardingham, G. E., & Lipton, S. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3573 · Cited by 64 · see citing works
Self-citationWahl, A.-S., Buchthal, B., Rode, F., Bomholt, S. F., Freitag, H. E., Hardingham, G. E., Rønn, L. C. B., & Bading, H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.018 · Cited by 64 · see citing works
Self-citationPGC-1α Negatively Regulates Extrasynaptic NMDAR Activity and Excitotoxicity
Puddifoot, C. A., Martel, M., Soriano, F. X., Camacho‐Morales, A., Vidal‐Puig, A., Wyllie, D. J. A., & Hardingham, G. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6407-11.2012 · Cited by 63 · see citing works
Self-citationGenetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia
Schwartz, T. L., Sachdeva, S., & Stahl, S. M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799958594 · Cited by 46 · see citing works
Regulation of N-Methyl-D-Aspartate Receptors by Disrupted-in-Schizophrenia-1
Wei, J., Graziane, N., Wang, H., Zhong, P., Wang, Q., Liu, W., Hayashi‐Takagi, A., Korth, C., Sawa, A., Brandon, N. J., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.009 · Cited by 44 · see citing works
Gupta, K., Chandran, S., & Hardingham, G. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12022 · Cited by 38 · see citing works
Self-citationLi, M., Chiu, J., Kelsen, A., Lu, S. C.-L., & Fukagawa, N. K. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22197 · Cited by 38 · see citing works
The Possible Involvement of NMDA Glutamate Receptor in the Etiopathogenesis of Bipolar Disorder
Fountoulakis, K. Ν. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799958585 · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215 · see citing works
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584 · see citing works
Neuroprotective Effect of Antioxidants in the Brain
Lee, K. H., Cha, M., & Lee, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197152 · Cited by 527 · see citing works
López-Fabuel, I., Douce, J. L., Logan, A., James, A. M., Bonvento, G., Murphy, M. P., Almeida, Á., & Bolaños, J. P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613701113 · Cited by 474 · see citing works
Hasel, P., Dando, O., Jiwaji, Z., Baxter, P. S., Todd, A., Heron, S., Márkus, N. M., McQueen, J., Hampton, D. W., Torvell, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15132 · Cited by 305 · see citing works
Self-citationLinking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304 · see citing works
Self-citationShandilya, S., Kumar, S., Jha, N. K., Kesari, K. K., & Ruokolainen, J. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.005 · Cited by 300 · see citing works
The origin of NMDA receptor hypofunction in schizophrenia
Nakazawa, K., & Sapkota, K. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 277 · see citing works
Quantitative real-time imaging of glutathione
Jiang, X., Chen, J., Bajić, A., Zhang, C., Song, X., Carroll, S. L., Cai, Z., Tang, M., Xue, M., Cheng, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms16087 · Cited by 270 · see citing works
Bioenergetics and redox adaptations of astrocytes to neuronal activity
Bolaños, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13486 · Cited by 262 · see citing works
Adaptive regulation of the brain’s antioxidant defences by neurons and astrocytes
Baxter, P. S., & Hardingham, G. E. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.027 · Cited by 235 · see citing works
Self-citationJiwaji, Z., Tiwari, S. S., Avilés-Reyes, R. X., Hooley, M., Hampton, D., Torvell, M., Johnson, D. A., McQueen, J., Baxter, P., Sabari-Sankar, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27702-w · Cited by 223 · see citing works
Self-citationGlutathione in Brain Disorders and Aging
Iskusnykh, I. Y., Zakharova, A. A., & Pathak, D. (2022) · Molecules · doi:10.3390/molecules27010324 · Cited by 213 · see citing works
Regulation of neuronal development and function by ROS
Oswald, M. C. W., Garnham, N., Sweeney, S. T., & Landgraf, M. (2018) · FEBS Letters · doi:10.1002/1873-3468.12972 · Cited by 210 · see citing works
Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour
Vicente‐Gutiérrez, C., Bonora, N., Bobo-Jiménez, V., Jiménez-Blasco, D., López-Fabuel, I., Fernández, E., Joséphine, C., Bonvento, G., Enrı́quez, J. A., Almeida, Á., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0031-6 · Cited by 205 · see citing works
The Glutathione System in Parkinson’s Disease and Its Progression
Bjørklund, G., Peana, M., Maes, M., Dadar, M., & Severin, B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.004 · Cited by 186 · see citing works
Bell, K. F. S., Al-Mubarak, B., Martel, M.-A., McKay, S., Wheelan, N., Hasel, P., Márkus, N. M., Baxter, P., Deighton, R. F., Serio, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms8066 · Cited by 191 · see citing works
Self-citationMitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 189 · see citing works
Inflammation in schizophrenia: A question of balance
Leza, J. C., García‐Bueno, B., Bioque, M., Arango, C., Parellada, M., Kim, Q., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 183 · see citing works
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
Barron, H., Hafizi, S., Andreazza, A. C., & Mizrahi, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030651 · Cited by 176 · see citing works
The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases
Todd, A., & Hardingham, G. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249607 · Cited by 170 · see citing works
Self-citationGlutathione and glutamate in schizophrenia: a 7T MRS study
Kumar, J., Liddle, E. B., Fernandes, C. C., Palaniyappan, L. K., Hall, E. L., Robson, S. E., Simmonite, M., Jan, F., Katshu, M. Z. U. H., Qureshi, A., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0104-7 · Cited by 154 · see citing works
The role of glutathione redox imbalance in autism spectrum disorder: A review
Bjørklund, G., Tinkov, A. A., Hosnedlová, B., Kizek, R., Ajsuvakova, O. P., Chirumbolo, S., Геннадиевна, С. М., Peana, M., Dadar, M., El-Ansary, A. K., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.017 · Cited by 150 · see citing works
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Vallée, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052810 · Cited by 153 · see citing works
Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
Murray, A., Rogers, J. C., Katshu, M. Z. U. H., Liddle, P. F., & Upthegrove, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.703452 · Cited by 147 · see citing works
Cuénod, M., Steullet, P., Cabungcal, J.-H., Dwir, D., Khadimallah, I., Klauser, P., Conus, P., & Kim, Q. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01374-w · Cited by 129 · see citing works
Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain
Li, J., Tian, M., Hua, T., Wang, H., Yang, M., Li, W., Zhang, X., & Yuan, H. (2021) · Autophagy · doi:10.1080/15548627.2021.1900498 · Cited by 123 · see citing works
Teng, M., Zhao, X., Wu, F., Wang, C., Wang, C., White, J. C., Zhao, W., Zhou, L., Yan, S., & Tian, S. (2022) · Environment International · doi:10.1016/j.envint.2022.107154 · Cited by 120 · see citing works
Das, T. K., Javadzadeh, A., Dey, A., Sabesan, P., Théberge, J., Raduà, J., & Palaniyappan, L. K. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.006 · Cited by 114 · see citing works
Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
Nakazawa, K., Jeevakumar, V., & Nakao, K. (2017) · npj Schizophrenia · doi:10.1038/s41537-016-0003-3 · Cited by 110 · see citing works
Potential Roles of Redox Dysregulation in the Development of Schizophrenia
Perkins, D. O., Jeffries, C. D., & Do, K. Q. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.016 · Cited by 103 · see citing works
Tsugawa, S., Noda, Y., Tarumi, R., Mimura, Y., Yoshida, K., Iwata, Y., ElSalhy, M., Kuromiya, M., Kurose, S., Masuda, F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845820 · Cited by 99 · see citing works
Advantages and Limitations of Animal Schizophrenia Models
Białoń, M., & Wąsik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115968 · Cited by 97 · see citing works
Cathepsin B is an executioner of ferroptosis
Nagakannan, P., Islam, M. R., Conrad, M., & Eftekharpour, E. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118928 · Cited by 96 · see citing works
Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins
Pemberton, J. M., Pogmore, J. P., & Andrews, D. W. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00654-2 · Cited by 90 · see citing works
Recent insights on astrocyte mechanisms in CNS homeostasis, pathology, and repair
Hart, C. G., & Karimi‐Abdolrezaee, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24922 · Cited by 85 · see citing works
Monte, A. S., Mello, B. S. F., Borella, V., Araújo, T. D. S., da Silva, F. E. R., de Sousa, F. C. F., de Oliveira, A. C. P., Gama, C. S., Seeman, M. V., Vasconcelos, S. M. M., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.057 · Cited by 76 · see citing works
The impact of glutathione metabolism in autism spectrum disorder
Bjørklund, G., Doşa, M. D., Maes, M. H. J., Dadar, M., Frye, R. E., Peana, M., & Chirumbolo, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105437 · Cited by 77 · see citing works
Ben‐Azu, B., Aderibigbe, A. O., Eneni, A.-E. O., Ajayi, A. M., Umukoro, S., & Iwalewa, E. O. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2590-z · Cited by 74 · see citing works
eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response
Jan, A., Jansonius, B., Delaidelli, A., Somasekharan, S. P., Bhanshali, F., Vandal, M., Negri, G. L., Moerman, D. G., Mackenzie, I. R., Calon, F., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1634-1 · Cited by 73 · see citing works
Boas, S. M., Joyce, K. L., & Cowell, R. M. (2021) · Antioxidants · doi:10.3390/antiox11010008 · Cited by 69 · see citing works
Haddad, M., Hervé, V., Ben Khedher, M. R., Rabanel, J.-M., & Ramassamy, C. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8129 · Cited by 68 · see citing works
Booker, S. A., de Oliveira, L. S., Anstey, N. J., Kozić, Z., Dando, O., Jackson, A. D., Baxter, P. S., Isom, L. L., Sherman, D. L., Hardingham, G. E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107988 · Cited by 66 · see citing works
Self-citationReactive Oxygen Species in the Regulation of the GABA Mediated Inhibitory Neurotransmission
González, A. N. B., Pazos, M. I. L., & Calvo, D. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.064 · Cited by 65 · see citing works
Vitamin D in Central Nervous System: Implications for Neurological Disorders
Sailike, B., Onzhanova, Z., Akbay, B., Tokay, T., & Molnár, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147809 · Cited by 66 · see citing works
Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1
McQueen, J., Ryan, T. J., McKay, S., Marwick, K. F. M., Baxter, P. S., Carpanini, S. M., Wishart, T. M., Gillingwater, T. H., Manson, J. C., Wyllie, D. J. A., et al. (2017) · eLife · doi:10.7554/elife.17161 · Cited by 55 · see citing works
Self-citationSynapse Pruning: Mitochondrial ROS with Their Hands on the Shears
Cobley, J. N. (2018) · BioEssays · doi:10.1002/bies.201800031 · Cited by 53 · see citing works
Brightness and shadows of mitochondrial ROS in the brain
Jiménez-Blasco, D., Almeida, Á., & Bolaños, J. P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106199 · Cited by 48 · see citing works
Bellozi, P. M. Q., Lima, I. V. D. A., Doria, J. G., Vieira, É. L. M., Campos, A. C., Candelario‐Jalil, E., Reis, H. J., Teixeira, A. L., Ribeiro, F. M., & de Oliveira, A. C. P. (2016) · Scientific Reports · doi:10.1038/srep25226 · Cited by 47 · see citing works
Depp, C., Orth, C. B., Schroeder, L., Hellwig, A., & Bading, H. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7092 · Cited by 46 · see citing works
Dissecting the neurobiology of linguistic disorganisation and impoverishment in schizophrenia
Palaniyappan, L. K. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.08.015 · Cited by 47 · see citing works
Cabungcal, J.-H., Steullet, P., Kraftsik, R., Cuénod, M., & Kim, Q. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.02.017 · Cited by 45 · see citing works
Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity
Segura‐Aguilar, J., Mannervik, B., Inzunza, J., Varshney, M., Nalvarte, I., & Muñoz, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335690 · Cited by 45 · see citing works
Nagakannan, P., & Eftekharpour, E. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.005 · Cited by 43 · see citing works
Cardis, R., Cabungcal, J.-H., Dwir, D., Kim, Q., & Steullet, P. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.10.006 · Cited by 42 · see citing works
McKay, S., Ryan, T. J., McQueen, J., Indersmitten, T., Marwick, K. F. M., Hasel, P., Kopanitsa, M. V., Baxter, P. S., Martel, M.-A., Kind, P. C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.089 · Cited by 42 · see citing works
Self-citationAstrocyte Molecular Clock Function in the Nucleus Accumbens Is Important for Reward-Related Behavior
Becker‐Krail, D. D., Ketchesin, K. D., Burns, J. N., Zong, W., Hildebrand, M. A., DePoy, L. M., Vadnie, C. A., Tseng, G. C., Logan, R. W., Huang, Y. H., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.02.007 · Cited by 42 · see citing works
Corcoba, A., Steullet, P., Duarte, J. M. N., van de Looij, Y., Monin, A., Cuénod, M., Rolf Gruetter, A., & Kim, Q. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv110 · Cited by 40 · see citing works
Hoque, A., Hossain, M. I., Ameen, S. S., Ang, C., Williamson, N. A., Ng, D. C. H., Chüeh, A. C., Roulston, C. L., & Cheng, H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.009 · Cited by 40 · see citing works
Limongi, R., Jeon, P., Théberge, J., & Palaniyappan, L. K. (2021) · Antioxidants · doi:10.3390/antiox10010075 · Cited by 38 · see citing works
Gómez‐Vicente, V., Lax, P., Fernández‐Sánchez, L., Rondón, N., Esquiva, G., Germaín, F., de la Villa, P., & Cuenca, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137826 · Cited by 36 · see citing works
CDK5 knockdown in astrocytes provide neuroprotection as a trophic source via Rac1
Posada‐Duque, R., Palacio-Castañeda, V., & Cardona‐Gómez, G. P. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.07.001 · Cited by 35 · see citing works
Bellozi, P. M. Q., Gomes, G. F., da Silva, M. C. M., Lima, I. V. D. A., Batista, C. R. Á., Carneiro, W. D. O., Doria, J. G., Vieira, É. L. M., Vieira, R. P., de Freitas, R. P., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107785 · Cited by 33 · see citing works
Márkus, N. M., Hasel, P., Qiu, J., Bell, K. F. S., Heron, S., Kind, P. C., Dando, O., Simpson, T. I., & Hardingham, G. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148164 · Cited by 35 · see citing works
Self-citationHasam‐Henderson, L. A., Gotti, G. C., Mishto, M., Klisch, C., Gerevich, Z., Geiger, J. R. P., & Kovács, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-27830-2 · Cited by 33 · see citing works
NMDA receptor modulation of glutamate release in activated neutrophils
del Arroyo, A. G., Hadjihambi, A., Sanchez, J., Turovsky, E. A., Kasymov, V., Cain, D. J., Nightingale, T. D., Lambden, S., Grant, S. G. N., Gourine, A. V., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.004 · Cited by 32 · see citing works
The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
Bhandari, R., Kaur, J., Kaur, S., & Kuhad, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1887141 · Cited by 32 · see citing works
Mååg, J. L. V., Kaczorowski, D. C., Panja, D., Peters, T. J., Bramham, C. R., Wibrand, K., & Dinger, M. E. (2017) · BMC Genomics · doi:10.1186/s12864-017-3621-x · Cited by 31 · see citing works
Bygrave, A. M., Kilonzo, K., Kullmann, D. M., Bannerman, D. M., & Kätzel, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00835 · Cited by 32 · see citing works
Borella, V., Seeman, M. V., Cordeiro, R. C., Santos, J. V. D., de Souza, M. R. M., Fernandes, E. N. D. S., Monte, A. S., Vasconcelos, S. M. M., Quinn, J. P., de Lucena, D. F., et al. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22329 · Cited by 31 · see citing works
Intertwined ROS and Metabolic Signaling at the Neuron-Astrocyte Interface
Vicente‐Gutiérrez, C., Jiménez-Blasco, D., & Quintana–Cabrera, R. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02965-9 · Cited by 29 · see citing works
JNK signalling regulates antioxidant responses in neurons
Ugbode, C., Garnham, N., Fort‐Aznar, L., Evans, G. J. O., Chawla, S., & Sweeney, S. T. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101712 · Cited by 30 · see citing works
Contreras, M. L., de la Fuente-Ortega, E., Vargas-Robert, S., Muñoz, D. C., Goic, C. A., & Haeger, P. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00338 · Cited by 29 · see citing works
Targeted de-repression of neuronal Nrf2 inhibits α-synuclein accumulation
Baxter, P. S., Márkus, N. M., Dando, O., He, X., Al-Mubarak, B. R., Qiu, J., & Hardingham, G. E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03507-z · Cited by 29 · see citing works
Self-citationMixed-species RNA-seq for elucidation of non-cell-autonomous control of gene transcription
Qiu, J. L., Dando, O., Baxter, P. S., Hasel, P., Heron, S., Simpson, T. I., & Hardingham, G. E. (2018) · Nature Protocols · doi:10.1038/s41596-018-0029-2 · Cited by 29 · see citing works
Self-citationVillanueva, J. R., Esteban, J. M., & Villanueva, L. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020094 · Cited by 26 · see citing works
Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia
Zhang, Y., Catts, V. S., & Weickert, C. S. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417728805 · Cited by 26 · see citing works
Potential Novel Therapies for Neurodevelopmental Diseases Targeting Oxidative Stress
Curpăn, A.-Ș., Luca, A.-C., & Ciobica, A. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6640206 · Cited by 23 · see citing works
Antioxidant-induced reductive stress has untoward consequences on the brain microvasculature
Fisher, D. W., & Mentor, S. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206640 · Cited by 22 · see citing works
Hagenston, A. M., Bading, H., & Orth, C. B. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035287 · Cited by 22 · see citing works
Zhu, J., Xu, S., Li, S., Yang, X., Yu, X., & Zhang, X. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00976 · Cited by 21 · see citing works
Zajkowska, I., Niczyporuk, P., Urbaniak, A. D., Tomaszek, N., Modzelewski, S., & Waszkiewicz, N. (2024) · Nutrients · doi:10.3390/nu16142228 · Cited by 22 · see citing works
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders
Haroon, E., & Miller, A. H. (2017) · Modern trends in psychiatry · doi:10.1159/000470805 · Cited by 21 · see citing works
Burnside, S. W., & Hardingham, G. E. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170013 · Cited by 21 · see citing works
Self-citationSampaio, L. R. L., Filho, F. M. S. C., de Almeida, J. C., Diniz, D. D. S., Patrocínio, C. F. V., de Sousa, C. N. S., Patrocínio, M. C. A., Macêdo, D. S., & Vasconcelos, S. M. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.008 · Cited by 21 · see citing works
Sun, W., Yang, Y., Wu, Z., Chen, X., Li, W., & An, L. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00355-9 · Cited by 20 · see citing works
Chloride co‐transporters as possible therapeutic targets for stroke
Baudel, M. A. S. M., Poole, A. V., & Darlison, M. G. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13901 · Cited by 18 · see citing works
Khorani, M., Bobe, G., Matthews, D. G., Magaña, A. A., Caruso, M. A., Gray, N. E., Quinn, J. F., Stevens, J. F., Soumyanath, A., & Maier, C. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215084 · Cited by 18 · see citing works
Hagenston, A. M., Yan, J., Orth, C. B., Tan, Y.-W., Sekler, I., & Bading, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101508 · Cited by 18 · see citing works
Beeraka, N. M., Ávila-Rodriguez, M., & Aliev, G. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02703-4 · Cited by 18 · see citing works
Glutathione induces GABA release through P2X7R activation on Müller glia
Freitas, H. R., & Reis, R. A. D. M. (2017) · Neurogenesis · doi:10.1080/23262133.2017.1283188 · Cited by 18 · see citing works
Schizophrenia and Glutathione: A Challenging Story
Carletti, B., Banaj, N., Piras, F., & Bossù, P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111526 · Cited by 17 · see citing works
Neuronal Activity and Its Role in Controlling Antioxidant Genes
Qiu, J., Dando, O., Febery, J. A., Fowler, J. H., Chandran, S., & Hardingham, G. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061933 · Cited by 17 · see citing works
Self-citationFoley, T. D. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00672-w · Cited by 16 · see citing works
Kolář, D., Krajčovič, B., Kletečková, L., Kunčická, D., Valeš, K., & Brožka, H. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad066 · Cited by 16 · see citing works
Lee, S. W., Kim, S., Chang, Y., Cha, H., Noeske, R., Choi, C., & Lee, S. J. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.08.018 · Cited by 14 · see citing works
Modelling fluorescence lifetimes with TD-DFT: a case study with syn-bimanes
Wong, Z. C., Fan, W. Y., Chwee, T. S., & Sullivan, M. B. (2016) · RSC Advances · doi:10.1039/c6ra11495d · Cited by 14 · see citing works
Eneni, A.-E. O., Ben‐Azu, B., Ajayi, A. M., & Aderibigbe, A. O. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100210 · Cited by 12 · see citing works
Nanjaiah, N. D., Ramaswamy, P., Goswami, K., Hurmath, F. K., & Borkotokey, M. (2019) · Cell Biology International · doi:10.1002/cbin.11193 · Cited by 12 · see citing works
Synaptic Activity Regulates Mitochondrial Iron Metabolism to Enhance Neuronal Bioenergetics
Tena‐Morraja, P., Riqué‐Pujol, G., Müller‐Sánchez, C., Reina, M., Martínez-Estrada, O. M., & Soriano, F. X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020922 · Cited by 11 · see citing works
- Authors
- Baxter, P. S., Bell, K. F. S., Hasel, P., Kaindl, A. M., Fricker, M., Thomson, D., Cregan, S. P., Gillingwater, T. H., & Hardingham, G. E.
- Affiliations
- University of Edinburgh (GB)
- Charité – Universitätsmedizin Berlin (DE)
- University of Cambridge (GB)
- Western University (CA)
- Corresponding author
- Hardingham, Giles E.
- ORCID
- Venue
- Nature Communications
- Published
- 2015-04-09
- Volume
- 6
- Issue
- 1
- Pages
- 6761-6761
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4403319
- OpenAlex
- W2168888447
- Cited by
- 139
- References
- 73
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 8 · 2023: 11 · 2022: 13 · 2021: 17 · 2020: 16 · 2019: 13 · 2018: 13 · 2017: 17 · 2016: 11 · 2015: 6
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-09-11)
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- NOVA (University of Newcastle Australia) (submittedVersion, cc-by)
- Funders
- Sonnenfeld Stiftung
- Wellcome Trust
- Deutsche Forschungsgemeinschaft (SFB 665)
- Berlin Institute of Health
- Directorate for Biological Sciences
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- NMDA receptor, glutathione system, synaptic activity, redox homeostasis, antioxidant defense, glutathione synthesis, reactive oxygen species scavenging, Nrf2, astrocytes, neurodevelopmental disorders, gene expression regulation, neurodegeneration
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, Cerebral Cortex, Frontal Lobe, Gene Expression Regulation, Glutathione, Glutathione Peroxidase, Glutathione Transferase, Neurons, Transcription, Genetic, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Rats, Sprague-Dawley, Apoptosis, Reactive Oxygen Species, Mice, Knockout, Excitatory Amino Acid Antagonists, Tumor Suppressor Proteins, Apoptosis Regulatory Proteins, NF-E2-Related Factor 2, Mice, Rats, Electrical Synapses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review